Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/16/2005CN1594592A PCR detection method for eel vibrio
03/16/2005CN1594591A Method for screening aerobic denitrifying bacteria
03/16/2005CN1594588A Feature sequence amplification mark closely interlocked with Chinese cabbage tangerine core character and obtaining method thereof
03/16/2005CN1594571A Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005CN1594552A Protein conformational disease cell model and its use
03/16/2005CN1594284A Enzyme-linked clenbuterol and method for producing same
03/16/2005CN1193230C Method and device and measuring member for measuring concentration of substances in liquids
03/16/2005CN1193229C 生物传感器 Biosensor
03/16/2005CN1193220C Organism tissue staining method
03/16/2005CN1193105C Micro sprue system of array biochip
03/16/2005CN1193104C Method for testing application of interleukin-2 gene in chronic pain
03/16/2005CN1193103C Diagnosis kit for mycobacterium species identification and drug-resistance detection and mfg. method thereof
03/16/2005CN1193102C Melanocortin-4 receptor gene and use as genetic marker for fat content, weight gain, and/or feed consumption animals
03/16/2005CN1193101C Tissue chip and cellline chip for observation of cell signal conducting path
03/16/2005CN1193096C Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/16/2005CN1193093C Primer for diagnosis of one or more kinds of cancer
03/15/2005US6867347 Transplantation of cells into humans; obtain cells, transform cells, graft cells into human, monitor human for defective phenotype
03/15/2005US6867342 Surgical drapes that incorporate a fluid control film; wound dressings
03/15/2005US6867290 Nucleotide sequences for use as tools in human therapeutics and diagnostics
03/15/2005US6867289 Thio-modified aptamer synthetic methods and compositions
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867197 Method of targeting conjugate molecules to mitochondria
03/15/2005US6867052 Bioassay comprising chromogenic indicators for diagnostic detection and identification of pathological agents; food processing; sterilization; medicine
03/15/2005US6867045 Diagnosing and screening subjects for a thromboembolic disorder by analyzing the clotting time of a sample in the presence and absence of activated Protein C (APC) and compared with a standard
03/15/2005US6867042 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis
03/15/2005US6867039 Oligonucleotides, specifically hybridizable with nucleic acids encoding dual specific phosphatase 5
03/15/2005US6867035 Cell libraries indexed to nucleic acid microarrays
03/15/2005US6867034 Methods of screening novel agents for use in cancer therapy and prevention
03/15/2005US6867027 RNA polymerase
03/15/2005US6867021 Multiplex RT-PCR/PCR for simultaneous detection of bovine coronavirus, bovine rotavirus, Cryptosporidium parvum, and Escherichia coli
03/15/2005US6867018 Enzyme and enzymatic procedures for cleaving the beta secretase cleavage site of the amyloid protein precursor (APP) and associated nucleic acids, peptides, vectors, cells and cell isolates and assays for identifying drug candidates
03/15/2005US6867016 Reagents and methods useful for detecting diseases of the gastrointestinal tract
03/15/2005US6867015 Detection of residues of antibiotics such as penicillin G and sulfadiazine in liquid samples such as milk, meat juice, serum, urine
03/15/2005US6867014 By reaction of homocysteine and L-serine to form cystathionine by the enzyme cystathionine beta -synthase (CBS) and the enzymatic conversion by cystathionine beta -lyase (CBL) of cystathionine to homocysteine, pyruvate and ammonia
03/15/2005US6867013 Methods of screening for antagonists and agonists of polypeptides having kinase functions
03/15/2005US6867012 Determination method of biological component and reagent kit used therefor
03/15/2005US6867010 Enzyme activity screen with direct substrate reloading
03/15/2005US6867007 Binary or polynary targeting and uses thereof
03/15/2005US6867003 Grb14, Grb14 fusion proteins, and screening methods
03/15/2005US6867002 Sample treating kit and sample treating method using the same for analysis with a biosensor
03/15/2005US6866999 Method for identifying increased risk of death from community acquired pneumonia
03/15/2005US6866998 Cellular assays for identifying signaling peptides
03/15/2005US6866997 Designing a protein which is capable of binding to any predefined nucleic acid sequence
03/15/2005US6866996 Using molecular and evolutionary techniques to identify polynucleotide and polypeptide sequences corresponding to evolved traits that may be relevant to human diseases or conditions,such as resistance to hepatitis C virus (HCV)
03/15/2005US6866995 Method to enable assessment of growth and death of micro-organisms
03/15/2005US6866993 MDA-9 and uses thereof
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005US6866824 Apparatus for use in the detection of preferential particles in sample
03/15/2005US6866134 Method and apparatus for document processing
03/15/2005CA1341476C Moleculary cloned acquired immunodeficiency syndrome polypeptides and their methods of use
03/12/2005CA2447400A1 Brain tumor stem cells
03/10/2005WO2005022167A2 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
03/10/2005WO2005022164A2 Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8)
03/10/2005WO2005022162A1 Quantum dots and methods of use thereof
03/10/2005WO2005022160A2 Diagnosis and treatment of micobacterial infections
03/10/2005WO2005022159A1 Method for density measurement of mycelium and uses thereof
03/10/2005WO2005022153A2 Compositions and methods for screening using populations of surrogate antibodies which comprise aptamers
03/10/2005WO2005022151A1 Film layer for detection of immobilized analytes
03/10/2005WO2005022143A2 Method and apparatus for assay of electrochemical properties
03/10/2005WO2005022142A1 Biomolecule detecting element and method for analyzing nucleic acid using the same
03/10/2005WO2005022119A2 Methods for detecting and quantifying specific microorganisms
03/10/2005WO2005022118A2 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
03/10/2005WO2005021804A1 Multiplex detection compositions, methods, and kits
03/10/2005WO2005021803A1 Improved bisulfite method employing size exclusion step
03/10/2005WO2005021802A2 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil
03/10/2005WO2005021801A2 Pathogenic gene for coronary artery disease
03/10/2005WO2005021800A2 Detection and quantitation of nucleic acid molecules in biological samples
03/10/2005WO2005021799A2 Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
03/10/2005WO2005021798A1 Multi-allelic molecular detection of sars-associated coronavirus
03/10/2005WO2005021797A1 Process of treating sea algae and halophytic plants
03/10/2005WO2005021796A2 Chrna2 genetic markers associated with galantamine response
03/10/2005WO2005021795A1 Nucleotide sequences specific to brucella and methods for the detection of brucella
03/10/2005WO2005021794A2 Ola-based methods for the detection of target nucleic acid sequences
03/10/2005WO2005021793A1 Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
03/10/2005WO2005021792A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
03/10/2005WO2005021791A1 Method of evaluating effect of external stimulus by using vital cells, kit for performing the method and system of evaluating effect on external stimulus
03/10/2005WO2005021790A2 Use of gene sequences specific for mycobacterium tuberculosis and their related proteins for diagnosis and prevention of tubercular infection
03/10/2005WO2005021789A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same and uses thereof
03/10/2005WO2005021788A1 Identification of an erbb2 gene expression signature in breast cancer
03/10/2005WO2005021787A2 Human obesity susceptibility gene and uses thereof
03/10/2005WO2005021786A1 A method of sequencing nucleic acids by ligation of labelled oligonucleotides
03/10/2005WO2005021785A1 Standards in pcr
03/10/2005WO2005021784A2 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
03/10/2005WO2005021783A2 New use of gain and loss of notch2 function in brain tumors and the new notch2 genetic alterations of the notch2 gene per se
03/10/2005WO2005021782A1 Methods of identifying modulators of proteasome activity
03/10/2005WO2005021781A2 Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9)
03/10/2005WO2005021780A1 Signal amplification using a synthetic zymogen
03/10/2005WO2005021779A1 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
03/10/2005WO2005021778A2 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021775A2 Method for identifying selective growth inhibitors
03/10/2005WO2005021767A1 Tumor-specific expression of reporter genes
03/10/2005WO2005021766A1 Regulatable gene expression in mammalian cells and mammals
03/10/2005WO2005021755A1 Compositions, methods, and kits for fabricating coded molecular tags
03/10/2005WO2005021753A1 Probe carrier and method for quantifying target substance using the probe carrier
03/10/2005WO2005021745A1 Hepatocellular cancer-associated gene
03/10/2005WO2005021744A1 Digital cell